Dorothy Hester
Primary Care · Sparks, MDNPI 1932940004
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations.
Across 100 payments — averaging $19.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$430
- AbbVie$342
- AstraZeneca$334
- Pfizer$228
- Boehringer Ingelheim$110
- Lilly USA, LLC$73
- plus $459 from 13 others
What the payments were for
- Food & beverage$1,93298%
- Education$432%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 20 | $430 |
| AbbVie | 21 | $342 |
| AstraZeneca | 16 | $334 |
| Pfizer | 12 | $228 |
| Boehringer Ingelheim | 4 | $110 |
| Lilly USA, LLC | 4 | $73 |
| Phathom Pharmaceuticals, Inc. | 4 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Astellas Pharma US Inc | 2 | $49 |
| Bayer | 2 | $46 |
| Mannkind Corporation | 1 | $43 |
| Amgen | 2 | $39 |
| Esperion Therapeutics, Inc. | 2 | $37 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Lundbeck LLC | 1 | $23 |
| Ardelyx, Inc. | 1 | $20 |
| Abbott | 1 | $20 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Exact Sciences | 1 | $15 |
How this compares
$1,975 in reported general payments places this provider in the 85th percentile of 191 primary care providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $487 |
| Levothyroxine Sodium | 18 | $385 |
| Metoprolol Succinate | 25 | $270 |
| Fluticasone Propionate | 15 | $115 |
| Lisinopril | 18 | $111 |
| Amlodipine Besylate | 17 | $88 |
| Azithromycin | 11 | $85 |
| Atorvastatin Calcium | 14 | $77 |
| Losartan Potassium | 11 | $58 |
| Metformin Hcl | 13 | $56 |
Paid to pharmacies, not to this prescriber.
Other primary care in Sparks
- Ashley SalamoneBaltimore$13K
- Ololade IkuomolaBaltimore$10K
- Patricia GoodmanUppr Marlboro$8K
- Jody LeonardAnnapolis$7K
- Yury MalachevskyBaltimore$7K
- Kyleen DavisChevy Chase$6K
- Laura Ferguson-WeigmanBel Air$5K
- Roza LissGaithersburg$5K
- Anita Tuli-KendallGaithersburg$5K
- Hannah WhiteheadEssex$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.